Search research articles
Contact Us
Filters
Showing results (31-40 of 312) with videos related to
Page
of 32
Sort By:
International Journal of Antimicrobial Agents
|
January 30, 2008
Pharmacodynamics of doxycycline for chemoprophylaxis of Lyme disease: preliminary findings and possible implications for other antimicrobials
Jooyun Lee, Gary P Wormser
Expert Review of Anti-Infective Therapy
|
June 12, 2014
Is there a role for generic antiretroviral drugs in the United States?
Gary P Wormser, Thomas Lappas
Infection Control and Hospital Epidemiology
|
June 23, 2015
The Slippery Slope of Mandatory Quarantine for Healthcare Workers with Exposure to Ebola--Let's Do the Math
Gary P Wormser, Eugene D Shapiro
JAMA
|
December 19, 2018
Controversies About Lyme Disease-Reply
Eugene D Shapiro, Gary P Wormser
JAMA
|
November 20, 2008
Nosocomial transmission of human granulocytic anaplasmosis?
Peter J Krause, Gary P Wormser
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2007
Reinfection in patients with Lyme disease
Robert B Nadelman, Gary P Wormser
Diagnostic Microbiology and Infectious Disease
|
July 31, 2020
COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic
Stanley H Weiss, Gary P Wormser
The New England Journal of Medicine
|
March 15, 2013
Reinfection versus relapse in Lyme disease
Robert B Nadelman, Gary P Wormser
Antimicrobial Agents and Chemotherapy
|
August 27, 2014
Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone
Charles S Pavia, Gary P Wormser
International Journal of Antimicrobial Agents
|
January 5, 2021
Passive immunization and its rebirth in the era of the COVID-19 pandemic
Charles S Pavia, Gary P Wormser
Page
of 32
Search research articles
Search
Showing results (31-40 of 312) with videos related to
Sort By:
Page
of 32
International Journal of Antimicrobial Agents
|
January 30, 2008
Pharmacodynamics of doxycycline for chemoprophylaxis of Lyme disease: preliminary findings and possible implications for other antimicrobials
Jooyun Lee, Gary P Wormser
Expert Review of Anti-Infective Therapy
|
June 12, 2014
Is there a role for generic antiretroviral drugs in the United States?
Gary P Wormser, Thomas Lappas
Infection Control and Hospital Epidemiology
|
June 23, 2015
The Slippery Slope of Mandatory Quarantine for Healthcare Workers with Exposure to Ebola--Let's Do the Math
Gary P Wormser, Eugene D Shapiro
JAMA
|
December 19, 2018
Controversies About Lyme Disease-Reply
Eugene D Shapiro, Gary P Wormser
JAMA
|
November 20, 2008
Nosocomial transmission of human granulocytic anaplasmosis?
Peter J Krause, Gary P Wormser
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2007
Reinfection in patients with Lyme disease
Robert B Nadelman, Gary P Wormser
Diagnostic Microbiology and Infectious Disease
|
July 31, 2020
COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic
Stanley H Weiss, Gary P Wormser
The New England Journal of Medicine
|
March 15, 2013
Reinfection versus relapse in Lyme disease
Robert B Nadelman, Gary P Wormser
Antimicrobial Agents and Chemotherapy
|
August 27, 2014
Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone
Charles S Pavia, Gary P Wormser
International Journal of Antimicrobial Agents
|
January 5, 2021
Passive immunization and its rebirth in the era of the COVID-19 pandemic
Charles S Pavia, Gary P Wormser
Page
of 32